| Match | Type | Why |
|---|
| Chlorothiazide in the treatment of toxemia of pregnancy. | Academic Article |
Why?
|
| Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia. | Academic Article |
Why?
|
| Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. | Academic Article |
Why?
|
| Maternal pre-eclampsia/eclampsia and the risk of sudden infant death syndrome in offspring. | Academic Article |
Why?
|
| A multivariate analysis of risk factors for preeclampsia. | Academic Article |
Why?
|
| Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. | Academic Article |
Why?
|
| Insulin resistance and preeclampsia in gestational diabetes mellitus. | Academic Article |
Why?
|
| Low-dose aspirin for prevention of morbidity and mortality from preeclampsia. | Academic Article |
Why?
|
| Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. | Academic Article |
Why?
|
| Preterm preeclampsia: 32 to 37 weeks gestation. | Academic Article |
Why?
|
| Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies. | Academic Article |
Why?
|
| A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia. | Academic Article |
Why?
|
| Antidepressant medication use, depression, and the risk of preeclampsia. | Academic Article |
Why?
|
| Preeclampsia Onset, Days to Delivery, and Autism Spectrum Disorders in Offspring: Clinical Birth Cohort Study. | Academic Article |
Why?
|
| Preeclampsia Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force. | Academic Article |
Why?
|